Intravenous infusion of total dose iron in peritoneal dialysis patients : A critical appraisalFISHBANE, S.American journal of kidney diseases. 1998, Vol 32, Num 6, pp 1086-1090, issn 0272-6386Article

Hyporesponsiveness to recombinant human erythropoietin in dialysis patientsFISHBANE, S.Dialysis & transplantation. 2000, Vol 29, Num 9, pp 545-548, issn 0090-2934, 581 [3 p.]Article

Exercise-induced renal and electrolyte changes: minimizing the risksFISHBANE, S.Physician and sportsmedicine. 1995, Vol 23, Num 8, pp 39-46, issn 0091-3847, 6 p.Article

Treating chronic renal insufficiency : The nephrologist vs. the internist : (A commentary)FISHBANE, S.Dialysis & transplantation. 2000, Vol 29, Num 8, pp 472-474, issn 0090-2934Article

Refractory anemia in a patient with allergy to intravenous iron drugsFISHBANE, S.Kidney international. 2006, Vol 69, Num 10, pp 1910-1913, issn 0085-2538, 4 p.Article

«In any case there are no sinful thoughts» ― the role and status of women in Jewish law as expressed in the Arukh HashulhanFISHBANE, S.Judaism. 1993, Vol 42, Num 168, pp 492-503, issn 0022-5762Article

Review of issues relating to iron and infectionFISHBANE, S.American journal of kidney diseases. 1999, Vol 34, Num 4, pp S47-S52, issn 0272-6386, SUP2Article

Iron management in end-stage renal diseaseFISHBANE, S; MAESAKA, J. K.American journal of kidney diseases. 1997, Vol 29, Num 3, pp 319-333, issn 0272-6386Article

The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patientsFISHBANE, S; LYNN, R. I.Clinical nephrology. 1995, Vol 44, Num 4, pp 238-240, issn 0301-0430Article

The new FDA label for erythropoietin treatment : How does it affect hemoglobin target?FISHBANE, S; NISSENSON, A. R.Kidney international. 2007, Vol 72, Num 7, pp 806-813, issn 0085-2538, 8 p.Article

The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patientsFISHBANE, S; LYNN, R. I.American journal of kidney diseases. 1995, Vol 25, Num 3, pp 426-432, issn 0272-6386Article

The process owner in quality improvementFISHBANE, S; JOHNSON, D.Dialysis & transplantation. 1998, Vol 27, Num 9, pp 550-553, issn 0090-2934Article

Regulation of renal urate excretion : A critical reviewMAESAKA, J. K; FISHBANE, S.American journal of kidney diseases. 1998, Vol 32, Num 6, pp 917-933, issn 0272-6386Article

Iron treatment : Impact of safety issuesFISHBANE, S.American journal of kidney diseases. 1998, Vol 32, Num 6, pp 152-156, issn 0272-6386, SUP4Conference Paper

Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patientsRUGGIAN, J. C; MAESAKA, J. K; FISHBANE, S et al.American journal of kidney diseases. 1996, Vol 28, Num 3, pp 409-414, issn 0272-6386Article

Ankle-arm blood pressure index as a marker for atherosclerotic vascular diseases in hemodialysis patientsFISHBANE, S; SUGKEE YOUN; KOWALSKI, E. J et al.American journal of kidney diseases. 1995, Vol 25, Num 1, pp 34-39, issn 0272-6386Article

Is there material hazard to treatment with intravenous iron?FISHBANE, S; MAESAKA, J. K; MITTAL, S. K et al.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 11, pp 2595-2598, issn 0931-0509Conference Paper

Role of volume overload in dialysis-refractory hypertensionFISHBANE, S; NATKE, E; MAESAKA, J. K et al.American journal of kidney diseases. 1996, Vol 28, Num 2, pp 257-261, issn 0272-6386Article

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationFISHBANE, S; FREI, G. L; MAESAKA, J et al.American journal of kidney diseases. 1995, Vol 26, Num 1, pp 41-46, issn 0272-6386Article

The effect of KT/V_urea on nitrogen appearance and appetite in peritoneal dialysisLYNN, R. I; FISHBANE, S; GINSBERG, N. S et al.Peritoneal dialysis international. 1995, Vol 15, Num 5, pp S50-S52, issn 0896-8608, SUPConference Paper

Cerebral salt-wasting syndrome : Does it exist?MAESAKA, J. K; GUPTA, S; FISHBANE, S et al.Nephron. 1999, Vol 82, Num 2, pp 100-109, issn 0028-2766Article

Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patientsDEVITA, M. V; FRUMKIN, D; MITTAL, S et al.Clinical nephrology. 2003, Vol 60, Num 5, pp 335-340, issn 0301-0430, 6 p.Article

Partial characterization of apoptotic factor in Alzheimer plasmaMAESAKA, J. K; PALAIA, T; CHOWDHURY, S. A et al.American journal of physiology. Renal physiology. 1999, Vol 45, Num 4, pp F521-F527, issn 1931-857XArticle

Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patientsFISHBANE, S; GALGANO, C; LANGLEY, R. C et al.Kidney international. 1997, Vol 52, Num 1, pp 217-222, issn 0085-2538Conference Paper

Page / 2